Results 171 to 180 of about 7,093,593 (187)

HTA147 Advanced Therapy Medicinal Products (ATMPS) Market Access Challenges in France

Value in Health, 2022
K Hoceini, M Tano, V Siorat, O Parent de Curzon, A Degrassat-Théas, P Paubel   +5 more
openaire   +1 more source

Evaluation of Institutional Readiness at Sites Within the UK NHS Using a Novel Advanced Therapy Medicinal Product Assessment Tool

Regenerative Medicine, 2021
Ruaridh Buchan, Lisa Wotherspoon
exaly  

STABILITY ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS)

Cytotherapy
S. Perujo Rosado, J. Chaparro García, L. Kazantseva, R. Maldonado Sánchez, L. Santos Ruiz, A. Rodríguez Acosta   +5 more
openaire   +1 more source

[Advanced therapy medicinal products' (ATMP) pharmaceutical circuit in France: Current situation and outlook].

Annales pharmaceutiques francaises
Advanced therapy medicinal products' reconstitution is an innovative pharmaceutical activity. The purpose of this work is to evaluate the current situation in France within hospital pharmacies.An electronic questionnaire (90 questions) was sent to previously identified French pharmaceutical teams exploring advanced therapy medicinal products ...
Benjamin, Fabri, Guillaume, Sicard, Laurence, Gauthier-Villano, Bertrand, Pourroy   +3 more
openaire   +1 more source

J006 Surgical delivery of advanced therapy medicinal products (ATMPs) to the brain

J: Clinical therapeutics
William Gray, Romina Aron Badin
openaire   +1 more source

HTA21 Evolving Landscapes for Advanced Therapy Medicinal Products (ATMPS): Access in the US, UK, & EU

Value in Health, 2022
M Smith, S Matthijsse
openaire   +1 more source

Hurdles in clinical implementation of academic advanced therapy medicinal products: A national evaluation

Cytotherapy, 2016
Henk-Jan Guchelaar, Pauline Meij
exaly  

Bringing Advanced Therapy Medicinal Products (ATMPs) to the Clinic and Beyond: How to Ensure the Sustainable and Affordable Introduction of ATMPs Into Healthcare

2022
openaire   +1 more source

People also looked at

Frontiers in Immunology, 2012
Jänis Ancans
exaly   +2 more sources

Development of an Advanced Therapy Medicinal Product (ATMP) for the treatment of knee cartilage lesions

Since 1994, Autologous Chondrocyte Implantation (ACI) has been performed in Europe, initially by placing a suspension of cells in an articular cartilage defect that was occluded with periosteum and subsequently combining the cells with a matrix, which serve as a skeleton to place cells into the defect.
openaire   +1 more source